| Friday 3 September, 2010 |
GöteborgBIO
Medicinaregatan 8A
SE- 413 46 Göteborg
Sweden
Phone: +46 (0)31 - 61 24 02
Fax: +46 (0)31 - 41 97 00
Despite the current recession, total R&D investments in Europe increased by 8.1 percent in 2008. This is in line with previous years´ increases, according to the EU Commission´s Industrial R&D Investment Scoreboard.
Sweden is now number two on the list of European countries with the largest increase in research investment. Here, companies invested 17 percent more on R&D than they did the year before, while Italy tops the ranking with an increase of 20.4 percent.
Most funds are invested in the life science sector. In the global perspective, 18.9 percent of R&D investments went to the biotech and pharmaceuticals sectors in 2008.Furthermore, it is in the life science sector that research has the highest intensity according to the report. This intensity is measured as the ratio between investments in R&D and the company´s net sales. In biotech and pharmaceuticals, intensity in 2008 was 16.1 percent globally, compared with the second-placed software and computer technology sector, with 9.6 percent.
Source: Biotech Swede
n
